Karuna Pharmaceuticals   Report issue

For profit Phase 3
Founded: Boston Massachusetts United States (2009)

Organization Overview

First Clinical Trial
2016
NCT02831231
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Karuna Pharmaceuticals | Karuna Therapeutics